• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

着丝粒和拓扑异构酶特异性免疫反应与系统性硬化症微血管病变程度的关系。

Association Between Centromere- and Topoisomerase-specific Immune Responses and the Degree of Microangiopathy in Systemic Sclerosis.

机构信息

N.M. van Leeuwen, MD, C.M. Wortel, MSc, C.M. Fehres, PhD, H.U. Scherer, MD, PhD, R.E.M Toes, Professor, MSc, PhD, T.W. Huizinga, Professor, MD, PhD, J.K. de Vries-Bouwstra, MD, PhD, Department of Rheumatology, Leiden University Medical Center;

N.M. van Leeuwen, MD, C.M. Wortel, MSc, C.M. Fehres, PhD, H.U. Scherer, MD, PhD, R.E.M Toes, Professor, MSc, PhD, T.W. Huizinga, Professor, MD, PhD, J.K. de Vries-Bouwstra, MD, PhD, Department of Rheumatology, Leiden University Medical Center.

出版信息

J Rheumatol. 2021 Mar;48(3):402-409. doi: 10.3899/jrheum.191331. Epub 2020 Jun 1.

DOI:10.3899/jrheum.191331
PMID:32482649
Abstract

OBJECTIVE

Autoreactive antibody responses, including the use of several isotypes of autoantibodies, have been shown to be associated with clinical outcome in several rheumatic autoimmune diseases. The goals of this study were to evaluate whether (1) anticentromere antibody (ACA)- and antitopoisomerase antibody (ATA)-specific isotype expression, and (2) organ involvement are associated with the degree of microangiopathy in systemic sclerosis (SSc).

METHODS

ACA and ATA IgG, IgM, and IgA levels were measured in baseline serum samples of ACA IgG-positive (+) and ATA IgG+ patients with SSc. The degree of microangiopathy was determined based on nailfold videocapillaroscopy (NVC) images collected at the same point in time. Logistic regression analyses with autoantibodies, clinical characteristics, isotype expression, and ACA and ATA IgG, IgM, and IgA levels as independent variables, and NVC pattern as the dependent variable were performed.

RESULTS

In 164 patients, isotype levels and degree of microangiopathy were evaluated. Logistic regression confirmed the association of the degree of microangiopathy with the presence of digital ulcers (OR 3.07, 95% CI 1.43-6.60), interstitial lung disease (OR 3.41, 95% CI 1.11-10.61), and pulmonary arterial hypertension (OR 5.58, 95% CI 2.05-17.81). ATA positivity was associated with more severe microangiopathy (OR 2.09, 95% CI 1.05-4.13). Patients who expressed solely ACA IgG showed a trend towards less severe microangiopathy compared to patients also expressing ACA IgM and/or IgA. Levels of ACA IgG and ATA IgM were found to be associated with microangiopathy severity.

CONCLUSION

We observed an association between ACA and ATA responses and the degree of microangiopathy in SSc. These findings might indicate that the breadth of the autoimmune response, as reflected by autoantibody production and microvascular damage, interacts in the pathophysiology of SSc.

摘要

目的

自身反应性抗体反应,包括几种自身抗体同种型的使用,已被证明与几种风湿性自身免疫性疾病的临床结果相关。本研究的目的是评估(1)着丝粒抗体(ACA)和拓扑异构酶抗体(ATA)特异性同种型表达,以及(2)器官受累是否与系统性硬化症(SSc)的微血管病变程度相关。

方法

在 ACA IgG 阳性(+)和 ATA IgG+ SSc 患者的基线血清样本中测量 ACA 和 ATA IgG、IgM 和 IgA 水平。微血管病变程度基于同时采集的甲褶毛细血管镜(NVC)图像确定。使用逻辑回归分析,将自身抗体、临床特征、同种型表达以及 ACA 和 ATA IgG、IgM 和 IgA 水平作为自变量,NVC 模式作为因变量。

结果

在 164 名患者中评估了同种型水平和微血管病变程度。逻辑回归证实微血管病变程度与存在手指溃疡(OR 3.07,95%CI 1.43-6.60)、间质性肺病(OR 3.41,95%CI 1.11-10.61)和肺动脉高压(OR 5.58,95%CI 2.05-17.81)相关。ATA 阳性与更严重的微血管病变相关(OR 2.09,95%CI 1.05-4.13)。与仅表达 ACA IgG 的患者相比,也表达 ACA IgM 和/或 IgA 的患者表现出更严重的微血管病变趋势。ACA IgG 和 ATA IgM 水平与微血管病变严重程度相关。

结论

我们观察到 ACA 和 ATA 反应与 SSc 中的微血管病变程度之间存在关联。这些发现可能表明,自身抗体产生和微血管损伤反映的自身免疫反应的广度在 SSc 的病理生理学中相互作用。

相似文献

1
Association Between Centromere- and Topoisomerase-specific Immune Responses and the Degree of Microangiopathy in Systemic Sclerosis.着丝粒和拓扑异构酶特异性免疫反应与系统性硬化症微血管病变程度的关系。
J Rheumatol. 2021 Mar;48(3):402-409. doi: 10.3899/jrheum.191331. Epub 2020 Jun 1.
2
Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis.抗拓扑异构酶,但不是系统性硬化症中的抗着丝点 B 细胞反应,显示与肺纤维化相关的活性、分泌 Ig 的细胞。
RMD Open. 2023 Jul;9(3). doi: 10.1136/rmdopen-2023-003148.
3
Could the IgA isotype provide additional information in systemic sclerosis patients? A retrospective study entailing IgA isotyping in a Mediterranean systemic sclerosis cohort.IgA 同种型能否为系统性硬化症患者提供更多信息?一项包含地中海地区系统性硬化症队列 IgA 分型的回顾性研究。
Clin Exp Rheumatol. 2024 Aug;42(8):1556-1563. doi: 10.55563/clinexprheumatol/qijvcj. Epub 2023 Sep 29.
4
Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.系统性硬化症中的甲襞微血管镜检查模式与血清自身抗体
Rheumatology (Oxford). 2004 Jun;43(6):719-26. doi: 10.1093/rheumatology/keh156. Epub 2004 Mar 16.
5
Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies.预测系统性硬化症患者的心肺受累:甲襞毛细血管镜图像和疾病特异性自身抗体的互补价值。
Rheumatology (Oxford). 2017 Jul 1;56(7):1081-1088. doi: 10.1093/rheumatology/kew402.
6
[Nailfold videocapillaroscopy in systemic sclerosis: diagnostic and follow-up parameters and correlation with both specific serum autoantibodies and subsets of skin involvement].系统性硬化症中的甲襞视频毛细血管镜检查:诊断及随访参数以及与特异性血清自身抗体和皮肤受累亚组的相关性
Reumatismo. 2004 Jan-Mar;56(1):36-45. doi: 10.4081/reumatismo.2004.36.
7
Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis.着丝粒抗体水平和同种型与系统性硬化症的发生。
Arthritis Rheumatol. 2021 Dec;73(12):2338-2347. doi: 10.1002/art.41814. Epub 2021 Nov 2.
8
Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis.系统性硬化症中甲襞微血管损伤和核抗体模式的进展。
J Rheumatol. 2013 May;40(5):634-9. doi: 10.3899/jrheum.121089. Epub 2013 Mar 1.
9
Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis.系统性硬化症患者中抗拓扑异构酶I抗体与抗着丝粒抗体的共存。
Ann Rheum Dis. 2002 Feb;61(2):121-7. doi: 10.1136/ard.61.2.121.
10
Smoking and systemic sclerosis: influence on microangiopathy and expression of anti-topoisomerase I antibodies in a monocentric cohort.吸烟与系统性硬化症:在单中心队列中对微血管病变和抗拓扑异构酶 I 抗体表达的影响。
Clin Exp Rheumatol. 2020 May-Jun;38 Suppl 125(3):25-28. Epub 2020 Mar 25.

引用本文的文献

1
Clinical manifestations and immune correlations in anti-centromere antibody-positive and anti-SSA/Ro antibody-positive primary Sjögren's syndrome: A retrospective analysis.抗着丝点抗体阳性和抗SSA/Ro抗体阳性的原发性干燥综合征的临床表现及免疫相关性:一项回顾性分析
PLoS One. 2025 Aug 15;20(8):e0322845. doi: 10.1371/journal.pone.0322845. eCollection 2025.
2
Pathogenic role of anti-nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseases.抗核自身抗体在系统性硬化症中的致病作用:来自其他风湿性疾病的见解
Immunol Rev. 2024 Nov;328(1):265-282. doi: 10.1111/imr.13390. Epub 2024 Sep 9.
3
Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosis.
自身抗体作为系统性硬化症中细胞功能障碍的潜在生物标志物和触发因素。
Curr Opin Rheumatol. 2025 Jan 1;37(1):51-63. doi: 10.1097/BOR.0000000000001035. Epub 2024 Aug 2.
4
The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis.可溶性晚期糖基化终产物受体可能对系统性硬皮病相关肺动脉高压具有预测价值。
Front Immunol. 2023 Jun 20;14:1189257. doi: 10.3389/fimmu.2023.1189257. eCollection 2023.
5
Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?抗核抗体在系统性硬化症中是否具有致病性作用?
Front Immunol. 2022 Jun 28;13:930970. doi: 10.3389/fimmu.2022.930970. eCollection 2022.
6
Clinical significance of serum ferritin in patients with systemic sclerosis.血清铁蛋白在系统性硬皮病患者中的临床意义。
J Clin Lab Anal. 2022 Aug;36(8):e24597. doi: 10.1002/jcla.24597. Epub 2022 Jul 9.
7
Capillaroscopy and Immunological Profile in Systemic Sclerosis.系统性硬化症中的毛细血管镜检查与免疫谱
Life (Basel). 2022 Mar 29;12(4):498. doi: 10.3390/life12040498.
8
Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis.着丝粒抗体水平和同种型与系统性硬化症的发生。
Arthritis Rheumatol. 2021 Dec;73(12):2338-2347. doi: 10.1002/art.41814. Epub 2021 Nov 2.